Theseus Pharmaceuticals, Inc.

Theseus Pharmaceuticals, Inc. - Enterprise Valueverified

THRX

Price:

$4.065

Market Cap:

$181.50M

Theseus Pharmaceuticals, Inc. is a biopharmaceutical company focused on discovering, developing, and bringing to market targeted treatments for cancer patients. Their leading investigational compound, THE-630, is a pan-KIT inhibitor undergoing Phase I clinical trials for treating gastrointestinal stromal tumors. The company is also advancing a fourth-generation EGFR inhibitor specifically designed to combat the C797S EGFR mutation, which confers resistance to initial or later-line osimertinib therapy in individuals with non-small cell lung cancer. All their research and development efforts aim to overcome drug resistance mutations within key driver oncogenes, which are mutated genes that pro...[Read more]

Industry

Biotechnology

IPO Date

2021-10-07

Stock Exchange

NASDAQ

Ticker

THRX

The Enterprise Value as of June 2026 (TTM) for Theseus Pharmaceuticals, Inc. (THRX) is 90.87M

According to Theseus Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 90.87M. This represents a change of -55.21% compared to the average of 202.88M of the last 4 quarters.

Theseus Pharmaceuticals, Inc. (THRX) Historical Enterprise Value (quarterly & annually)

How has THRX Enterprise Value performed in the past?

The mean historical Enterprise Value of Theseus Pharmaceuticals, Inc. over the last ten years is 311.03M. The current 90.87M Enterprise Value has changed 2.82% with respect to the historical average. Over the past ten years (40 quarters), THRX's Enterprise Value was at its highest in in the September 2021 quarter at 575.95M. The Enterprise Value was at its lowest in in the September 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

311.03M

Median

336.53M

Minimum

101.05M

Maximum

470.01M

Theseus Pharmaceuticals, Inc. (THRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Theseus Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual Enterprise Value = 470.01M

Minimum Annual Increase = -54.59%

Minimum Annual Enterprise Value = 101.05M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2022101.05M-51.92%
2021210.18M-54.59%
2020462.87M-1.52%

Theseus Pharmaceuticals, Inc. (THRX) Average Enterprise Value

How has THRX Enterprise Value performed in the past?

The current Enterprise Value of Theseus Pharmaceuticals, Inc. (THRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

258.04M

5-year avg

311.03M

10-year avg

311.03M

Theseus Pharmaceuticals, Inc. (THRX) Enterprise Value vs. Peers

How is THRX’s Enterprise Value compared to its peers?

Theseus Pharmaceuticals, Inc.’s Enterprise Value is greater than Vaccitech plc (-29134949.00), less than LENZ Therapeutics, Inc. (168.73M), less than LakeShore Biopharma Co., Ltd (405.01M), less than Spectrum Pharmaceuticals, Inc. (199.44M), less than F-star Therapeutics, Inc. (91.20M), greater than Alaunos Therapeutics, Inc. (4.90M), less than Zevra Therapeutics, Inc. (668.14M), greater than Selecta Biosciences, Inc. (28.41M), less than CARGO Therapeutics, Inc. Common Stock (109.02M), greater than aTyr Pharma, Inc. (45.86M),

Build a custom stock screener for Theseus Pharmaceuticals, Inc. (THRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Theseus Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Theseus Pharmaceuticals, Inc. (THRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Theseus Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Theseus Pharmaceuticals, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Theseus Pharmaceuticals, Inc. (THRX)?

What is the 3-year average Enterprise Value for Theseus Pharmaceuticals, Inc. (THRX)?

What is the 5-year average Enterprise Value for Theseus Pharmaceuticals, Inc. (THRX)?

How does the current Enterprise Value for Theseus Pharmaceuticals, Inc. (THRX) compare to its historical average?